{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:59:27Z","timestamp":1785473967556,"version":"3.56.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"\n Background<\/jats:title>\n At present, the risk factors contributing to the recurrence of papillary thyroid carcinoma (PTC) in residual thyroid tissue post-surgery are not yet fully understood. This study sought to identify multivariable predictors (MVPs) associated with such recurrence and to develop a dynamic, individualized nomogram. The objective is to establish a stratification framework to inform precision \u201crisk-intervention\u201d decision-making for patients at elevated risk of recurrence.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A cohort of 2,512 patients diagnosed with thyroid cancer and treated at the First Affiliated Hospital of Bengbu Medical University between January 2014 and December 2024 was analyzed. The cohort was stratified into a training set (n = 1,760) and a validation set (n = 752) using stratified random sampling with a 7:3 ratio. To address the class imbalance between recurrent and non-recurrent cases in the residual thyroid, the Random Over-Sampling Examples (ROSE) method was employed on the training set. Variable selection was conducted using univariate and multivariate logistic regression, LASSO regression, and standard stepwise regression based on the Akaike Information Criterion (AIC). A nomogram was subsequently developed by integrating the coefficients of the selected variables from the logistic regression model. The performance of the nomogram was assessed in both cohorts in terms of discrimination, calibration, and clinical utility.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In a study of 2,512 thyroid cancer patients who received primary treatment, 146 experienced recurrence in the remaining thyroid tissue. Using univariate and multivariate logistic regression and LASSO regression for feature selection, four independent predictors were identified for the final predictive model: maximum tumor diameter, number of metastatic lymph nodes, lymph node positivity rate, and age. The nomogram showed strong discriminatory ability, with an AUC of 0.7518 in the training set and 0.8347 in the validation set. It also demonstrated excellent calibration and clinical utility across all groups. The best cut-off value for the nomogram score to identify patients with residual thyroid recurrence was 0.245, with scores above this linked to a significantly worse postoperative outcome.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n We have developed and validated an innovative clinical prediction model specifically designed to assess the risk of recurrence in residual thyroid tissue. This model serves as a valuable tool for clinicians, facilitating personalized decision-making and representing a significant advancement in the postoperative management of papillary thyroid carcinoma.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fonc.2026.1827099","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:25:05Z","timestamp":1785471905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Internal validation of a residual thyroid recurrence model after PTC"],"prefix":"10.3389","volume":"16","author":[{"given":"Ruohan","family":"Shi","sequence":"first","affiliation":[{"name":"Department of the First Affiliated Hospital of Bengbu Medical University","place":["Bengbu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of the First Affiliated Hospital of Bengbu Medical University","place":["Bengbu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of the First Affiliated Hospital of Bengbu Medical University","place":["Bengbu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of the First Affiliated Hospital of Bengbu Medical University","place":["Bengbu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of the First Affiliated Hospital of Bengbu Medical University","place":["Bengbu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongsheng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of the First Affiliated Hospital of Bengbu Medical University","place":["Bengbu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1547345","article-title":"Age- and sex-specific impact on the progression of low-risk papillary thyroid carcinoma under active surveillance: a meta-analysis","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1163309","article-title":"Editorial: recent advances in papillary thyroid carcinoma: progression, treatment and survival predictors","volume":"14","author":"Volpi","year":"2023","journal-title":"Front Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf190","article-title":"Prospective validation of ata risk score for papillary thyroid microcarcinoma: an itco real-world study","volume":"110","author":"De Leo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184656","article-title":"Dynamic risk stratification integrated with ata risk system for predicting long-term outcome in papillary thyroid cancer","volume":"15","author":"Valerio","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvae012","article-title":"The american thyroid association risk classification of papillary thyroid cancer according to presurgery cytology","volume":"190","author":"Croce","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac646","article-title":"Current controversies in low-risk differentiated thyroid cancer: reducing overtreatment in an era of overdiagnosis","volume":"108","author":"Ullmann","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29468","article-title":"Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance","volume":"121","author":"Castro","year":"2015","journal-title":"Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6519","article-title":"Distinguishing recurrent thyroid cancer from residual nonmalignant thyroid tissue using multiphasic multidetector ct","volume":"41","author":"Debnam","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1363836","article-title":"Editorial: predictors for aggressiveness of papillary thyroid carcinoma","volume":"15","author":"Mezosi","year":"2024","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.789310","article-title":"Predictors and a prediction model for central cervical lymph node metastasis in papillary thyroid carcinoma (cn0)","volume":"12","author":"Gao","year":"2021","journal-title":"Front Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0209","article-title":"Predictive value of serum thyroglobulin for structural recurrence following lobectomy for papillary thyroid carcinoma","volume":"31","author":"Xu","year":"2021","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab836","article-title":"Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors","volume":"107","author":"Nieto","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.793997","article-title":"Features of lymph node metastasis and structural recurrence in papillary thyroid carcinoma located in the upper portion of the thyroid: a retrospective cohort study","volume":"12","author":"Heng","year":"2021","journal-title":"Front Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12539-021-00485-w","article-title":"Construction of a pearson- and mic-based co-expression network to identify potential cancer genes","volume":"14","author":"Cao","year":"2022","journal-title":"Interdiscip Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1642298","article-title":"Risk factors for predicting lateral lymph node metastasis of papillary thyroid carcinoma based on lasso-logistic regression","volume":"16","author":"Han","year":"2025","journal-title":"Front Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1109\/tvcg.2023.3326588","article-title":"A unified interactive model evaluation for classification, object detection, and instance segmentation in computer vision","volume":"30","author":"Chen","year":"2024","journal-title":"IEEE Trans Vis Comput Graph"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1084034","article-title":"Editorial: recent advances in papillary thyroid carcinoma: lymph node metastasis","volume":"13","author":"Carrillo","year":"2022","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae465","article-title":"Improving the risk prediction of the 2015 ata recurrence risk stratification in papillary thyroid cancer","volume":"110","author":"Wang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12022-023-09769-x","article-title":"Clinical and pathological features and gene expression profiles of clinically aggressive papillary thyroid carcinomas","volume":"34","author":"Metovic","year":"2023","journal-title":"Endocr Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1109\/tmi.2025.3588789","article-title":"Self-supervised upsampling for reconstructions with generalized enhancement in photoacoustic computed tomography","volume":"44","author":"Deng","year":"2025","journal-title":"IEEE Trans Med Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1350123","article-title":"Comparison of ultrasound risk stratification systems for pediatric thyroid nodules","volume":"15","author":"Yu","year":"2024","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1827099\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:25:06Z","timestamp":1785471906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1827099\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1827099"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1827099","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1827099"}}